Liv Mathiesen

• Mikaelsen, Helena Zaitzow; Ulla, Ingeborg Hjalland; Karimi, David; Mathiesen, Liv; Viktil, Kirsten Kilvik & Syversen, Malin Olsen [Vis alle 14 forfattere av denne artikkelen] (2024). Medication Discrepancies in Hospitalised Medical Patients – Status After a Decade With Targeted Medication Reconciliation Measures, a Cross-sectional Multicenter Study. Health Services Insights (HSI Journal). ISSN 1178-6329. 17. doi: 10.1177/11786329241254202.
• Mathiesen, Liv; Blix, Hege Salvesen; Molden, Espen; Kersten, Hege; Trapnes, Elin & Bergan, Stein [Vis alle 7 forfattere av denne artikkelen] (2024). Erfaringsbasert master i klinisk farmasi – en kartleggingsstudie. Norsk Farmaceutisk Tidsskrift. ISSN 0029-1935. s. 32–36. Vis sammendrag

  Hensikt Kartlegge bakgrunn for farmasøyter som har gjennomført minst halve det erfaringsbaserte masterprogrammet i klinisk farmasi ved Farmasøytisk institutt, Universitetet i Oslo. Kartlegge i hvilken grad arbeidsoppgavene har endret seg for de som har fullført utdanningen. Materiale og metode Deskriptiv nettbasert spørreskjemaundersøkelse med spørsmål knyttet til demografi, grunnutdanningen i farmasi, det erfaringsbaserte masterprogrammet og arbeidsoppgaver. Farmasøyter som hadde fullført minst tre av seks emner i masterprogrammet, kunne inkluderes, og 92 farmasøyter ble invitert til å delta. Resultater 82 farmasøyter (88 %) besvarte undersøkelsen, hvorav 53 hadde gjennomført hele utdanningen, og 29 farmasøyter hadde gjennomført minst halve utdanningen. Blant respondentene som hadde fullført masterprogrammet, hadde en signifikant høyere andel 5-årig farmasiutdanning (master i farmasi eller cand.pharm.) (p < 0,01) og jobbet i sykehus med klinisk farmasøytiske oppgaver før de startet på masterprogrammet (p = 0,04), sammenliknet med de som var underveis i utdanningen. Blant de som hadde fullført masterprogrammet, svarte 93 % at de hadde jobbet med klinisk farmasøytiske oppgaver etter utdanningen. Det var 70 % som for tiden utførte klinisk farmasøytiske arbeidsoppgaver, sammenliknet med 62 % før oppstart. 43 % hadde vært involvert i kliniske forskningsprosjekter etter endt utdanning. Konklusjon Blant de som var i ferd med å gjennomføre videreutdanningen var det flere med bachelorgrad og færre med erfaring som klinisk farmasøyt enn i gruppen som hadde fullført. Ni av ti farmasøyter som hadde gjennomført hele videreutdanningen, har hatt klinisk arbeidsoppgaver etterpå, mens seks av ti hadde slike oppgaver før utdanningen. Nesten halvparten hadde vært involvert i kliniske forskningsprosjekter.

• Mathiesen, Liv & Skovlund, Eva (2023). Avbrutte tidsserieanalyser. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 143(14). doi: 10.4045/tidsskr.23.0559. Fulltekst i vitenarkiv
• Rognan, Stine; Jørgensen, Mie Jedig; Mathiesen, Liv; Druedahl, Louise Christine; Lie, Helene Berg & Bengtsson, Kajsa Rebecka [Vis alle 8 forfattere av denne artikkelen] (2023). ‘The way you talk, do I have a choice?’ Patient narratives of medication decision-making during hospitalization. International Journal of Qualitative Studies on Health and Well-being. ISSN 1748-2623. 18(1). doi: 10.1080/17482631.2023.2250084. Fulltekst i vitenarkiv
• Hjemås, Bodil Jahren; Bøvre, Katrine; Bjerknes, Kathrin; Mathiesen, Liv; Mellingsæter, Marte & Molden, Espen (2023). Implementation of pharmacogenetic testing in medication reviews in a hospital setting. British Journal of Clinical Pharmacology. ISSN 0306-5251. 89(10), s. 3116–3125. doi: 10.1111/bcp.15815. Fulltekst i vitenarkiv
• Henriksen, Ben Tore; Krogseth, Maria; Andersen, Randi D.; Nordsveen, Maren; Thy Nguyen, Caroline & Mathiesen, Liv [Vis alle 7 forfattere av denne artikkelen] (2023). Clinical pharmacist intervention to improve medication safety for hip fracture patients through secondary and primary care settings: a nonrandomised controlled trial. Journal of Orthopaedic Surgery and Research. ISSN 1749-799X. 18(1). doi: 10.1186/s13018-023-03906-2. Fulltekst i vitenarkiv Vis sammendrag

  Background: Hip fracture patients face a patient safety threat due to medication discrepancies and adverse drug reactions when they have a combination of high age, polypharmacy and several care transitions. Consequently, optimised pharmacotherapy through medication reviews and seamless communication of medication information between care settings is necessary. The primary aim of this study was to investigate the impact on medication management and pharmacotherapy. The secondary aim was to evaluate implementation of the novel Patient Pathway Pharmacist intervention for hip fracture patients. Methods: Hip fracture patients were included in this nonrandomised controlled trial, comparing a prospective intervention group (n = 58) with pre-intervention controls who received standard care (n = 50). The Patient Pathway Pharmacist intervention consisted of the steps: (A) medication reconciliation at admission to hospital, (B) medication review during hospitalisation, (C) recommendation for the medication information in the hospital discharge summary, (D) medication reconciliation at admission to rehabilitation, and (E) medication reconciliation and (F) review after hospital discharge. The primary outcome measure was quality score of the medication information in the discharge summary (range 0-14). Secondary outcomes were potentially inappropriate medications (PIMs) at discharge, proportion receiving pharmacotherapy according to guidelines (e.g. prophylactic laxatives and osteoporosis pharmacotherapy), and all-cause readmission and mortality. Results: The quality score of the discharge summaries was significantly higher for the intervention patients (12.3 vs. 7.2, p < 0.001). The intervention group had significantly less PIMs at discharge (- 0.44 (95% confidence interval - 0.72, - 0.15), p = 0.003), and a higher proportion received prophylactic laxative (72 vs. 35%, p < 0.001) and osteoporosis pharmacotherapy (96 vs. 16%, p < 0.001). There were no differences in readmission or mortality 30 and 90 days post-discharge. The intervention steps were delivered to all patients (step A, B, E, F = 100% of patients), except step (C) medication information at discharge (86% of patients) and step (D) medication reconciliation at admission to rehabilitation (98% of patients). Conclusion: The intervention steps were successfully implemented for hip fracture patients and contributed to patient safety through a higher quality medication information in the discharge summary, fewer PIMs and optimised pharmacotherapy.

• Kållberg, Cecilia Birgit Maria; Mathiesen, Liv; Gopinathan, Unni & Blix, Hege Salvesen (2023). The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study. Journal of Pharmaceutical Policy and Practice. ISSN 2052-3211. 16. doi: 10.1186/s40545-023-00556-x. Fulltekst i vitenarkiv
• Syversen, Malin Olsen; Shah, Sarah Farhin; Mathiesen, Liv; Mowe, Morten & Lea, Marianne (2023). Effect of integrated medicines management on the quality of drug treatment in hospitalised multimorbid patients - a secondary endpoint analysis of a randomised controlled trial. International Journal of Pharmacy Practice (IJPP). ISSN 0961-7671. 31(3), s. 314–320. doi: 10.1093/ijpp/riad007. Fulltekst i vitenarkiv
• Henriksen, Ben Tore; Krogseth, Maria; Thy Nguyen, Caroline; Mathiesen, Liv; Andersen, Randi Dovland & Andersson, Yvonne [Vis alle 7 forfattere av denne artikkelen] (2022). Medication management for patients with hip fracture at a regional hospital and associated primary care units in Norway: a descriptive study based on a survey of clinicians' experience and a review of patient records. BMJ Open. ISSN 2044-6055. 12(11), s. 1–10. doi: 10.1136/bmjopen-2022-064868. Fulltekst i vitenarkiv Vis sammendrag

  Objective: Patients with hip fracture are at high risk of medication errors due to a combination of high age, comorbidities, polypharmacy and several care transitions after fracture. The aim was to study medication management tasks concerning patient safety: medication reconciliation, medication review and communication of key medication information in care transitions. Design: Descriptive study comprising a self-administered clinician survey (MedHipPro-Q) and a retrospective review of hospital medical records of patients with hip fracture. Setting: Regional hospital and the associated primary care units (South-Eastern Norway). Participants: The survey received responses from 253 clinicians, 61 medical doctors and 192 nurses, involved in the medication management of patients with hip fracture, from acute admittance to the regional hospital, through an in-hospital fast track, primary care rehabilitation and back to permanent residence. Respondents' representativeness was unknown, introducing a risk of selection and non-response bias, and extrapolating findings should be done with caution. The patient records review included a random sample of records of patients with hip fracture (n=50). Outcome measures: Medication reconciliation, medication review and communication of medication information from two perspectives: the clinicians' (ie, experiences with medication management) and the practice (ie, documentation of completed medication management). Results: In the survey, most clinicians stated they performed medication reconciliation (79%) and experienced that patients often arrived without a medication list after care transition (37%). Doctors agreed that more patients would benefit from medication reviews (86%). In the hospital patient records, completed medication reconciliation was documented in most patients (76%). Medication review was documented in 2 of 50 patients (4%). Discharge summary guidelines were followed fully for 3 of 50 patients (6%). Conclusion: Our study revealed a need for improved medication management for patients with hip fracture. Patients were at risk of medication information not being transferred correctly between care settings, and medication reviews seemed to be underused in clinical practice.

• Bengtsson, Kajsa Rebecka; Rognan, Stine; Kälvemark Sporrong, Sofia; Lie, Helene Berg; Andersson, Yvonne & Mowe, Morten [Vis alle 7 forfattere av denne artikkelen] (2022). Health literacy in medication communication during hospital discharge: a qualitative study at an internal medicines ward in Norway. BMJ Open. ISSN 2044-6055. 12(6), s. 1–8. doi: 10.1136/bmjopen-2021-058473. Fulltekst i vitenarkiv
• Kebede, Adyam Tesfamariam; Trapnes, Elin; Lea, Marianne; Abrahamsen, Bjørg & Mathiesen, Liv (2022). Effect of pharmacist-led inhaler technique assessment service on readmissions in hospitalized COPD patients: a randomized, controlled pilot study. BMC Pulmonary Medicine. ISSN 1471-2466. 22(1). doi: 10.1186/s12890-022-02004-z. Fulltekst i vitenarkiv
• Vallet, Thibault; Bensouda, Yahya; Saito, Jumpei; Mathiesen, Liv; Pokharkar, Varsha & Klingmann, Viviane [Vis alle 17 forfattere av denne artikkelen] (2021). Exploring Acceptability Drivers of Oral Antibiotics in Children: Findings from an International Observational Study. Pharmaceutics. ISSN 1999-4923. 13(10). doi: 10.3390/pharmaceutics13101721. Fulltekst i vitenarkiv
• Mulac, Alma; Mathiesen, Liv; Taxis, Katja & Granås, Anne Gerd (2021). Barcode medication administration technology use in hospital practice: a mixed-methods observational study of policy deviations. BMJ Quality and Safety. ISSN 2044-5415. 30(12), s. 1021–1030. doi: 10.1136/bmjqs-2021-013223. Fulltekst i vitenarkiv
• Svensberg, K.; Kalleberg, Birgitte Grøstad; Rosvold, E.O.; Mathiesen, Liv; Wøien, H. & Hove, L.H. [Vis alle 11 forfattere av denne artikkelen] (2021). Interprofessional education on complex patients in nursing homes: a focus group study. BMC Medical Education. ISSN 1472-6920. 21(1). doi: 10.1186/s12909-021-02867-6. Fulltekst i vitenarkiv Vis sammendrag

  Background An ageing population leads up to increasing multi-morbidity and polypharmacy. This demands a comprehensive and interprofessional approach in meeting patients’ complex needs. This study describes graduate students’ experiences of working practice based in interprofessional teams with complex patients’ care needs in nursing homes. Method Students from advanced geriatric nursing, clinical nutrition, dentistry, medicine and pharmacy at the University of Oslo in Norway were assigned to groups to examine and develop a care plan for a nursing home patient during a course. Focus groups were used, 21 graduate students participating in four groups. Data were collected during spring 2018, were inductively analysed according to a thematic analysis method (Systematic Text Condensation). An analytical framework of co-ordination practices was applied to get an in-depth understanding of the data. Results Three themes were identified: 1) Complex patients as learning opportunities- an eye-opener for future interprofessional collaboration 2) A cobweb of relations, and 3) Structural facilitators for new collective knowledge. Graduate university students experienced interprofessional education (IPE) on complex patients in nursing homes as a comprehensive learning arena. Overall, different co-ordination practices for work organization among the students were identified. Conclusions IPE in nursing homes facilitated the students’ scope from a fragmented approach of the patients towards a relational and collaborative practice that can improve patient care and strengthen understanding of IPE. The study also demonstrated the need for preparatory teamwork training to gain maximum benefit from the experience. Something that can be organized by the education institutions in the form of a stepwise learning module and as an online pre-training course in interprofessional teamwork. Further, focusing on the need for well thought through processes of the activity by the institutions and the timing the practice component in students’ curricula. This could ensure that IPE is experienced more efficient by the students.

• Svensberg, Karin; Kalleberg, Birgitte Grøstad; Mathiesen, Liv; Andersson, Yvonne; Rognan, Stine Eidhammer & Sporrong, Sofia Kälvemark (2021). The observer effect in a hospital setting - Experiences from the observed and the observers. Research in Social and Administrative Pharmacy. ISSN 1551-7411. 17(12), s. 2136–2144. doi: 10.1016/j.sapharm.2021.07.011. Fulltekst i vitenarkiv
• Rognan, Stine Eidhammer; Sporrong, Sofia Kälvemark; Bengtsson, Kajsa Rebecka; Lie, Helene Berg; Andersson, Yvonne & Mowe, Morten [Vis alle 7 forfattere av denne artikkelen] (2021). Empowering the patient? Medication communication during hospital discharge: a qualitative study at an internal medicines ward in Norway. BMJ Open. ISSN 2044-6055. doi: 10.1136/bmjopen-2020-044850. Fulltekst i vitenarkiv
• Rognan, Stine Eidhammer; Kälvemark Sporrong, Sofia; Lie, Helene Berg; Bengtsson, Kajsa Rebecka; Andersson, Yvonne & Mowe, Morten [Vis alle 7 forfattere av denne artikkelen] (2021). Discharge processes and medicines communication from the patient perspective: A qualitative study at an internal medicines ward in Norway. Health Expectations. ISSN 1369-6513. doi: 10.1111/hex.13232. Fulltekst i vitenarkiv
• Lea, Marianne; Mowe, Morten; Molden, Espen; Kvernrød, Kristin; Skovlund, Eva & Mathiesen, Liv (2020). Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial. BMJ Open. ISSN 2044-6055. 10. doi: 10.1136/bmjopen-2020-041558. Fulltekst i vitenarkiv
• Svensberg, Karin; Trapnes, Elin; Nguyen, Diana; Hasan, R.A.; Sund, Janne Kutschera & Mathiesen, Liv (2020). Patients’ perceptions of medicines information received at hospital discharge in Norway: a qualitative interview study. International Journal of Clinical Pharmacy. ISSN 2210-7703. s. 1–10. doi: 10.1007/s11096-020-01122-0.
• Lea, Marianne; Mowe, Morten; Mathiesen, Liv; Kvernrød, Kristin; Skovlund, Eva & Molden, Espen (2019). Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward. PLOS ONE. ISSN 1932-6203. 14(7). doi: 10.1371/journal.pone.0220071. Fulltekst i vitenarkiv
• Hjemås, Bodil Jahren; Bøvre, Katrine; Mathiesen, Liv; Lindstrøm, Jonas Christoffer & Bjerknes, Kathrin (2019). Interventional study to improve adherence to phosphate binder treatment in dialysis patients. BMC Nephrology. ISSN 1471-2369. 20(178). doi: 10.1186/s12882-019-1334-x. Fulltekst i vitenarkiv
• Holdhus, Hanne; Bøvre, Katrine; Mathiesen, Liv; Bjelke, Erik Börje & Bjerknes, Kathrin (2018). Limited effect of structured medication report as the only intervention at discharge from hospital. European Journal of Hospital Pharmacy (EJHP). ISSN 2047-9956. doi: 10.1136/ejhpharm-2017-001371.
• Johansen, Jeanette Schultz; Havnes, Kjerstin; Halvorsen, Kjell H.; Haustreis, Stine-Mari; Skaue, Lillann Wilsgård & Kamycheva, Elena [Vis alle 10 forfattere av denne artikkelen] (2018). Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (IMMENSE study): study protocol for a randomised controlled trial. BMJ Open. ISSN 2044-6055. 8:e020106, s. 1–8. doi: 10.1136/bmjopen-2017-020106. Fulltekst i vitenarkiv
• Høgholen, Anna Helene; Storhaug, Anette; Kvernrød, Kristin; Kostovski, Emil; Viktil, Kirsten Kilvik & Mathiesen, Liv (2018). Use of medicines, adherence and attitudes to medicines among persons with chronic spinal cord injury. Spinal Cord. ISSN 1362-4393. 56, s. 35–40. doi: 10.1038/sc.2017.95. Fulltekst i vitenarkiv
• Lea, Marianne; Barstad, Ingeborg; Mathiesen, Liv; Mowe, Morten & Molden, Espen (2016). Effect of teaching and checklist implementation on accuracy of medication history recording at hospital admission. International Journal of Clinical Pharmacy. ISSN 2210-7703. 38(1), s. 20–24. doi: 10.1007/s11096-015-0218-9.
• Holm, Hilde; Bjerke, Kirsti; Holst, Lone & Mathiesen, Liv (2015). Use of renal risk drugs in patients with renal impairment. International Journal of Clinical Pharmacy. ISSN 2210-7703. 37(6), s. 1136–1142. doi: 10.1007/s11096-015-0175-3.
• Christensen, Hege Staaland; Hestad, Anette Leirvik; Molden, Espen & Mathiesen, Liv (2011). CYP3A5-mediated metabolism of midazolam in recombinant systems is highly sensitive to NADPH-cytochrome P450 reductase activity. Xenobiotica. ISSN 0049-8254. 41(1), s. 1–5. doi: 10.3109/00498254.2010.523734.
• Christensen, Hege Staaland; Mathiesen, Liv; Postvoll, Lillian Wåge; Winther, Bjørn & Molden, Espen (2009). Different Enzyme Kinetics of Midazolam in Recombinant CYP3A4 Microsomes from Human and Insect Sources. Drug Metabolism and Pharmacokinetics (DMPK). ISSN 1347-4367. 24(3), s. 261–268.
• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1997). Hydrogen bond formation as a fundament for radical scavenging activity: A structure-activity study of C-methylated dihydrochalcones from Myrica gale and structurally related acetophenones. Free Radical Biology & Medicine. ISSN 0891-5849. 22, s. 307–311.
• Mathiesen, Liv; Wang, Siri; Halvorsen, Bente; Malterud, Karl Egil & Sund, Reidar Bredo (1996). Inhibition of lipid peroxidation in low density lipoprotein by the flavonoid myrigalone B and ascorbic acid. Biochemical Pharmacology. ISSN 0006-2952. 51, s. 1719–1725.
• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1996). Uncoupling of respiration and inhibition of ATP synthesis by C-methylated dihydrochalcones from Myrica gale L. European Journal of Pharmaceutical Sciences. ISSN 0928-0987. 4, s. 373–379.
• Mathiesen, Liv; Malterud, Karl Egil; Nenseter, Marit Sofie & Bredo Sund, Reidar (1996). Inhibition of low density lipoprotein oxidation by myrigalone B, a naturally occurring flavonoid. Pharmacology and Toxicology. ISSN 0901-9928. 78, s. 143–146. Vis sammendrag

  Abstract: The influence of myrigalone B, a flavonoid from the fruit exudate of Myrica gale L. on Cu2+ -induced oxidation of low density lipoprotein from cholesterol fed rabbits was investigated. Myrigalone B was an effective antioxidant, as shown by its ability to dose-dependently prolong the lag time for the formation of conjugated dienes. A 100 % increase in lag time corresponds to a myrigalone B concentration of 1.4+ 1.1 µM. For a-tocopherol, used as a reference, this effect corresponds to a concentration of 1.9+ 1.2 µM. Myrogalone B also dose-dependently reduced the maximum rate of formation of conjugated dienes, 1.4 µM causing a 15+ 5 % reduction, but it had no influence on the maximum amount of conjugated dienes formed.

• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1995). Antioxidant activity of fruit exudate and C-methylated dihydrochalcones from Myrica gale L. Planta Medica. ISSN 0032-0943. 61, s. 515–518.

Se alle arbeider i Cristin

• Syversen, Malin Olsen; Glatkauskas, Mikas; Benny, Steffi; Horgen, Kristine; Sedeniussen, Sandra Johanne & Hauge, Monica [Vis alle 12 forfattere av denne artikkelen] (2024). Medication discrepancies revealed by medication reconciliation after hospital discharge in patients with multiple long-term conditions.
• Glatkauskas, Mikas; Syversen, Malin Olsen; Scott, Michael; Svensberg, Karin; Denstad, Berit Gallefoss & Wibe, Torunn [Vis alle 7 forfattere av denne artikkelen] (2024). Application of a Human Factors and Systems Engineering Approach to Explore the Hospital to Home transition for patients with multiple long-term conditions.
• Viktil, Kirsten Kilvik; Kinnear, Moira; Lea, Marianne; Blix, Hege Salvesen & Mathiesen, Liv (2023). Teach the Teachers - Workplace based training in clinical pharmacy using patients as a learning resource.
• Syversen, Malin Olsen; Glatkauskas, Mikas; Lea, Marianne; Benny, Steffi; Horgen, Kristine & Svensberg, Karin [Vis alle 7 forfattere av denne artikkelen] (2023). Medication discrepancies after a hospital stay in patients with multiple long term conditions.
• Sporrong, Sofia Kälvemark; Kalleberg, Birgitte Grøstad; Mathiesen, Liv; Andersson, Yvonne; Rognan, Stine & Svensberg, Karin (2022). Understanding and addressing the observer effect in observation studies. I Desselle, Shane; Cardenas, Victoria Garcia; Anderson, Claire; Aslani, Parisa; Chen, Aleda & Chen, Timothy F. (Red.), Contemporary Research Methods in Pharmacy and Health Services. Academic Press. ISSN 9780323918886. s. 261–270.
• Viktil, Kirsten Kilvik; Mathiesen, Liv; Lea, Marianne & Blix, Hege Salvesen (2022). Styrking av ¬kliniske farmasøyters veiledningskompetanse. Norsk Farmaceutisk Tidsskrift. ISSN 0029-1935.
• Henriksen, Ben Tore; Andersen, Randi D.; Krogseth, Maria; Mathiesen, Liv; Davies, Maren Nordsveen & Andersson, Yvonne (2022). 5PSQ-003 Development and applicability of the MedHipPro-Q: a questionnaire assessing medical doctors’ experience with medication management in the hip fracture patient pathway.
• Rosvold, Elin Olaug; Svensberg, Karin; Kalleberg, Birgitte; Mathiesen, Liv; Hellesø, Ragnhild & Hove, Lene Hystad (2018). SamPraks Research Project at UiO.
• Lea, Marianne; Trapnes, Elin; Davidsson, Malin & Mathiesen, Liv (2017). Experiences from a pharmacist-led RCT in a hospital setting in Norway.
• Lea, Marianne; Mathiesen, Liv; Mowe, Morten & Molden, Espen (2017). Baseline characteristics of multimorbid patients included in an RCT.
• Lea, Marianne; Engnes, Anette; Mathiesen, Liv; Mowe, Morten & Molden, Espen (2016). Drug-related problems at hospital admission in multimorbid internal medical patients.
• Høgholen, Anna Helene; Storhaug, Anette; Kvernrød, Kristin; Kostovski, Emil; Viktil, Kirsten Kilvik & Mathiesen, Liv (2016). Adherence and attitudes to medicines among patients with chronic spinal cord injury.
• Holdhus, Hanne; Bøvre, Katrine; Mathiesen, Liv; Bjelke, Börje & Bjerknes, Kathrin (2016). Medication lists – Challenges in the communication between hospital and primary care service.
• Trapnes, Elin; Berge, Foss Jorunn; Lea, Marianne; Steen, Hanne; Davidsson, Malin & Mathiesen, Liv (2013). Implementing a Clinical Pharmacy Service in South East Norway.
• Hestad, Kristin; Lea, Marianne; Steen, Hanne; Njaastad, Anne Mette; Thomassen, Kristin & Mathiesen, Liv (2013). Legemiddelsamstemming.
• Lea, Marianne; Njaastad, Anne Mette; Thomassen, Kristin; Mathiesen, Liv; Ørnes, Silje Engdal & Flage, Marianne [Vis alle 7 forfattere av denne artikkelen] (2012). LegemiddelsamstemmingGenerell indremedisinsk sengepost, Medisinsk klinikk, Oslo Universitetssykehus HF.
• Christensen, Hege Staaland; Hestad, Anette L; Molden, Espen & Mathiesen, Liv (2009). Effect of NADPH-cytochrome P450 oxidoreductase on CYP3A5-mediated metabolism of midazolam.
• Christensen, Hege Staaland; Postvoll, Lillian W; Mathiesen, Liv; Johannesen, Siri & Molden, Espen (2007). Different CYP3A4 enzyme kinetics of midazolam in different microsomal preparations.
• Christensen, Hege Staaland; Postvoll, Lillian W; Mathiesen, Liv; Johannesen, Siri & Molden, Espen (2007). Different microsomal preparations exhibit different CYP3A4 enzyme kinetics of midazolam.
• Mathiesen, Liv; Midtvedt, Tore & Solberg, Claus Ola (2006). Daptomycin – et nytt antibiotikum mot hud- og bløtdelsinfeksjoner. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 126(18), s. 2383–2384.
• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1996). Hydrogenbinding som basis for radikalfangende aktivitet.
• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1996). Hydrogen bond formation as basis for radical scavenging activity.
• Wang, Siri; Mathiesen, Liv; Halvorsen, Bente; Malterud, Karl Egil & Sund, Reidar Bredo (1995). Inhibition of lipid peroxidation in human LDL by the flavonoid myrigalone B and ascorbic acid.
• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1995). Uncoupling of mitochondrial respiration by flavonoids from Myrica gale L.
• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1995). Uncoupling of mitochondrial respiration by flavonoids from Myrica gale L.
• Wang, Siri; Mathiesen, Liv; Halvorsen, Bente; Malterud, Karl Egil & Sund, Reidar Bredo (1995). Inhibition of lipid peroxidation in human LDL by the flavonoid myrigalone B and ascorbic acid.
• Mathiesen, Liv; Wang, Siri; Nenseter, Marit Sofie; Malterud, Karl Egil & Sund, Reidar Bredo (1994). Inhibition of lipid peroxidation in low density lipoprotein by myrigalon B, a naturally occurring flavonoid.
• Malterud, Karl Egil; Sund, Reidar Bredo; Lyckander, Inge M.; Mathiesen, Liv; Wang, Siri & Diep, Oanh Hong [Vis alle 8 forfattere av denne artikkelen] (1994). Bioactive naturally occurring phenols.
• Mathiesen, Liv; Wang, Siri; Halvorsen, Bente; Malterud, Karl Egil & Sund, Reidar Bredo (1994). Inhibition of lipid peroxidation in LDL by the flavonoid MyB and vitamin C.
• Mathiesen, Liv; Malterud, Karl Egil; Sund, Reidar Bredo & Nenseter, Marit Sofie (1993). Myrigalon B inhibits peroxidation of low density lipoprotein.
• Malterud, Karl Egil; Sund, Reidar Bredo; Mathiesen, Liv & Nenseter, Marit Sofie (1993). Inhibition of lipid peroxidation in low density lipoprotein by myrigalon B, a naturally occurring flavonoid.
• Mathiesen, Liv; Malterud, Karl Egil; Sund, Reidar Bredo & Osmundsen, Harald (1992). Antioxidant activity of Myrica gale fruit extract and of Myrigalon B.
• Malterud, Karl Egil; Sund, Reidar Bredo; Mathiesen, Liv & Nenseter, Marit Sofie (1992). Hemming av lipidperoksydering i LDL (low density lipoprotein) av myrigalon B, et flavonoid fra pors.
• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1992). Hemming av lipidperoksydering i mitokondrier av myrigalon B, et flavonoid fra pors.
• Mathiesen, Liv; Malterud, Karl Egil & Sund, Reidar Bredo (1992). Inhibition of lipid peroxidation in mitochondria by myrigalon B, a naturally occurring flavonoid.

Se alle arbeider i Cristin